Gilead to lay off 66 in office consolidation

Gilead Sciences is laying off up to 66 people as it closes its offices in Boulder and Westminster, Colorado, to consolidate its operations in California; the company hopes to relocate 73 of its 139 Colorado employees. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.